Annals of Nutrition and Metabolism

Original Paper

Galacto-Oligosaccharides Relieve Constipation in Elderly People

Teuri U.a,b · Korpela R.a-c

Author affiliations

a Valio Ltd, R&D Centre; b Institute of Biomedicine, Department of Pharmacology and Toxicology, University of Helsinki, and c Foundation for Nutrition Research, Helsinki, Finland

Related Articles for ""

Ann Nutr Metab 1998;42:319–327

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: January 20, 1999
Issue release date: November – December

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 4

ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)

For additional information: https://www.karger.com/ANM

Abstract

The aim of the study was to investigate whether galacto-oligosaccharides (GOS) relieve constipation in elderly people. The final study population consisted of 14 female subjects, mean age 79.6 (69–87) years, who suffered from constipation. The study was a double-blind two-period cross-over study. Both study periods lasted 2 weeks. The subjects ingested either 2 control yoghurts or 2 GOS-containing yoghurts daily. The yoghurts were otherwise similar, but the daily dose of GOS (Elix’or, BWP, Holland) from the GOS yoghurt was 9 g. The regular use of laxatives was stopped during the study periods and laxatives were used only when necessary. All the subjects reported the function of their intestines daily in a questionnaire. The defecation frequency per week (mean, range) was higher during the GOS period (7.1, 3–15) than during the control period (5.9, 1–14). GOS had no statistically significant effect on the use of laxatives, the consistency of feces or the ease of defecation, although GOS seemed to make defecation easier (p = 0.07). The adverse gastrointestinal symptoms were similar during both the control and the GOS periods. GOS seem to relieve constipation in most elderly people but the responses differ individually.




Related Articles:


References

  1. Murray FE, Bliss CM: Geriatric constipation: Brief update on a common problem. Geriatrics 1991;46:64–68.
  2. Corazziari E, Materia E, Bausano G, Torsoli A, Badiali D, Fanucci A, Fraracci L, Morini S, Capurso L, Montesi A, Pinzello G, Novara V: Laxative consumption in chronic nonorganic constipation. J Clin Gastroenterol 1987;9:427–430.
    External Resources
  3. Taylor R: Management of constipation. BMJ 1990;300:1063–1064.
  4. Muller-Lissner SA: Effect of wheat bran on weight of stool and gastrointestinal transit time: A meta analysis. BMJ 1988;296:615–617.
  5. Tanaka R, Takayama H, Morotomi M, Kuroshima T, Ueyama S, Matsumoto K, Kuroda A, Mutai M: Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobacteria Microflora 1983;2:17–24.
  6. Ohtsuka K, Tsuji K, Nakagawa Y, Ueda H, Ozawa O, Uchida T, Ichikawa T: Availability of 4′-galactosyllactose in rat. J Nutr Sci Vitaminol 1990;36:265–276.
  7. Ito M, Deguchi Y, Matsumoto K, Kimura M, Onodera N, Yajima T: Influence of galactooligosaccharides on the human fecal microflora. J Nutr Sci Vitaminol 1993;39:635–640.
  8. Ito M, Deguchi Y, Miyamori A, Matsumoto K, Kikuchi K, Matsumoto K, Kobayashi Y, Yajima T, Kan T: Effects of administration of galacto-oligosaccharides on the human fecal microflora, stool weight and abdominal sensation. Microbial Ecol 1990;3:285–292.
  9. Newburg DS: Do the binding properties of oligosaccharides in milk protect human infants from gastrointestinal bacteria. J Nutr 1997;127(suppl):980–984.
  10. Cummings JH: Constipation, dietary fiber and the control of large bowel function. Postgrad Med J 1984;60:811–819.
    External Resources
  11. Kleessen B, Sykura B, Zunft HJ, Blaut M: Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997;65:1397–1402.
  12. Hidaka H, Tashiro Y, Eida T: Proliferation of Bifidobacteria by oligosaccharides and their useful effect on human health. Bifidobacteria Microflora 1991;10:65–79.
  13. Shitara A: Effect of 4′-galactosyl-lactose on constipated old patient’s and intestinal bacteria. Med Biol 1988;117:371–373.
  14. Phillips SF: Diarrhea: A current view of the pathophysiology. Gastroenterology 1972;63:495–518.
    External Resources
  15. Marshall JB: Chronic constipation in adults. Postgrad Med 1990;88:49–63.
  16. Teuri U, Korpela R, Saxelin M, Montonen L, Salminen S: Increased fecal frequency and gastrointestinal symptoms following ingestion of galacto-oligosaccharide-containing yoghurt. J Nutr Sci Vitaminol 1998;44:465–471.
  17. Bouhnik Y, Flourie B, D’Agay-Abensour L, Pochart P, Gramet G, Durand M, Rambaud J-C: Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997;127:444–448.
  18. Whitehead WE, Chaussade S, Corazziari E, Kumar D: Report of an international workshop on management of constipation. Int J Gastroenterol 1991;4:99–113.
  19. Kot TV, Pettit-Young NA: Lactulose in the management of constipation: A current review. Ann Pharmacother 1992;26:1277–1282.
  20. Cummings JH: Short chain fatty acids in the human colon. Gut 1981;22:763–769.
  21. Hammer HF, Santa Ana CA, Schiller LR, Fordran JS: Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 1989;84:1056–1062.
  22. Hitchins AD, McDonough FE: Prophylactic and therapeutic aspects of fermented milk. Am J Clin Nutr 1989;49:675–684.
  23. Bennett A, Eley KG: Intestinal pH and propulsion: An explanation of diarrhoea in lactase deficiency and laxation by lactulose. J Pharm Pharmacol 1976;28:192–195.
    External Resources
  24. Stephen AM, Wiggins HS, Englyst HN, Cole TJ, Wayman BJ, Cummings JH: The effect of age, sex and the level of intake of dietary fiber from wheat on large-bowel function in thirty healthy subjects. Br J Clin Nutr 1986;56:349–361.
  25. Djouzi Z, Andrieux C: Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with human faecal microflora. Br J Nutr 1997;78:313–324.
  26. Ito M, Kimura M, Deguchi Y, Miyamori-Watabe A, Yajima T, Kan T: Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism. J Nutr Sci Vitaminol 1993;39:279–288.
  27. Florent C, Flourie B, Leblond A, Rautureau M, Bernier JJ, Rambaud JC: Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 1985;75:608–613.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: January 20, 1999
Issue release date: November – December

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 4

ISSN: 0250-6807 (Print)
eISSN: 1421-9697 (Online)

For additional information: https://www.karger.com/ANM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP